Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Oncogene|August 3, 2019
Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independenceWen-Bin Ou, Nan Ni, Rui Zuo, et al.
In Vivo (Athens, Greece)|September 3, 2020
A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion GeneAnastasios Kyriazoglou, Natalia Tourkantoni, Michalis Liontos, et al.
Cancer Diagnosis & Prognosis|May 6, 2024
Expression of DNA Repair Genes in Ewing SarcomaAnastasios Kyriazoglou, Myrto Moutafi, Eleni Zografos, et al.
Gynecologic Oncology|March 17, 2020
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapyMichalis Liontos, Maria Sotiropoulou, Maria Kaparelou, et al.
BMC Cancer|December 14, 2018
Management of uterine sarcomas and prognostic indicators: real world data from a single-institutionAnastasios Kyriazoglou, Michael Liontos, Dimitrios C Ziogas, et al.
Anti-Cancer Drugs|February 2, 2023
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigmAristotelis Bamias, Roubini Zakopoulou, Kimon Tzannis, et al.
British Journal of Cancer|May 23, 2025
Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell CarcinomaChristina Papanikolaou, Panagiota Economopoulou, Aris Spathis, et al.
Oncology Research and Treatment|March 23, 2021
Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 PatientsAnastasios Kyriazoglou, Iris Timmermans, Lore De Cock, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2025
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutionsStefania Kokkali, Ana Dolcan, Kjetil Boye, et al.
Oral Oncology|March 5, 2023
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis, et al.
Pageof 6